Skip to main content

Find Clinical Trials

Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

NCT00003853

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

University of Pavia Pavia, Italy

View Trial Details

Completed

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

NCT00513175

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +61 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

NCT00900406

Conditions: Adnexal Diseases, Blood Protein Disorders, Bone Marrow Diseases, +58 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)

NCT00322556

Conditions: Agammaglobulinemia, Blood Protein Disorders, Common Variable Immunodeficiency, +8 more
Locations: Contact CSL Behring for facility details Los Angeles, California, United States

Contact CSL Behring for facility details Centennial, Colorado, United States

Contact CSL Behring for facility details North Palm Beach, Florida, United States

Contact CSL Behring for facility details St. Petersburg, Florida, United States

View Trial Details

Completed

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

NCT00005622

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

NCT00960713

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +21 more
Locations: Service de médecine interne, hôpital Purpan, place du Dr Baylac Toulouse, France

View Trial Details

Completed

Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma

NCT00012350

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.

NCT00056550

Conditions: Antithrombin Deficiency, Congenital, Antithrombin III Deficiency, Blood Coagulation Disorders, +7 more
Locations: Marietta, Georgia, United States

Charleston, South Carolina, United States

Paris, France

Toulouse, France

View Trial Details

Completed

Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation

NCT00003143

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

NCT00920855

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Pacific Oncololgy & Hematology Encinitas, California, United States

Capitol Hematology Oncology Roseville, California, United States

University Of California, San Diego San Diego, California, United States

James R. Berenson, M.D., Inc. West Hollywood, California, United States

View all 13 locations

View Trial Details